Sold as Kwell. Every FDA application for this active ingredient: 2 branded and 10 generic.
As of Nov 13, 2026, FDA lists 12 applications for Lindane (sold as Kwell), with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Dec 19, 1974 | KwellANDA 84218 | Reed And Carnrick | 0 | Discontinued |
| Jan 22, 1975 | KwellANDA 84219 | Reed And Carnrick | 0 | Discontinued |
| Jun 15, 1976 | GameneANDA 84988 | Sola Barnes Hind | 0 | Discontinued |
| Jun 15, 1976 | GameneANDA 84989 | Sola Barnes Hind | 0 | Discontinued |
| Dec 17, 1981 | LindaneANDA 87266 | Olta Pharms | 16 | Discontinued |
| Dec 17, 1981 | LindaneANDA 87313 | Olta Pharms | 25 | Discontinued |
| Aug 16, 1984 | LindaneANDA 88190 | Wockhardt Bio AG | 17 | Discontinued |
| Sep 18, 1984 | LindaneANDA 88191 | Wockhardt Bio AG | 16 | Discontinued |
| — | ScabeneANDA 86769 | Stiefel | 0 | Discontinued |
| — | ScabeneANDA 87940 | Stiefel | 0 | Discontinued |
| — | KwellNDA 6309 | Reed And Carnrick | 0 | Discontinued |
| — | KwellNDA 10718 | Reed And Carnrick | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
